TOP2A (P4) is also associated with rapidly progressing cancers and relatively poor survival while EDDR1 (P15), a protein receptor kinase found to be over-expressed in ovarian cancers, is associated with poor prognosis and overall survival[8,32]. Here, TOP2A is linked to ovarian cancer.